These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 431654)

  • 21. Apparent theophylline half-life fluctuations during treatment of acute left ventricular failure.
    Jenne JW; Chick TW; Miller BA; Strickland RD
    Am J Hosp Pharm; 1977 Apr; 34(4):408-9. PubMed ID: 860722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [How do we use theophyllines?].
    Gea J; Ballester E; Montserrat JM; Mayordomo C; Picado C; Agustí Vidal A
    Med Clin (Barc); 1986 Mar; 86(9):366-8. PubMed ID: 3702529
    [No Abstract]   [Full Text] [Related]  

  • 23. Absolute bioavailability of oral theophylline.
    Hendeles L; Weinberger M; Bighley L
    Am J Hosp Pharm; 1977 May; 34(5):525-7. PubMed ID: 868891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics in drug therapy II: Applications of clinical pharmacokinetics in the assessment of theophylline therapy.
    Floyd RA; Cohen JL
    Am J Hosp Pharm; 1977 Apr; 34(4):402-7. PubMed ID: 871124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors that influence theophylline metabolism.
    Kozak PP
    West J Med; 1979 Oct; 131(4):319-20. PubMed ID: 506221
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacokinetic studies on proxyphylline administered intravenously and orally to man.
    Graffner C; Johnsson G; Sjögren J
    Acta Pharm Suec; 1973 Dec; 10(6):425-34. PubMed ID: 4773111
    [No Abstract]   [Full Text] [Related]  

  • 27. Reliability of theophylline clearance in determining chronic oral dosage regimens.
    Slotfeldt ML; Johnson CE; Grambau G; Weg JG
    Am J Hosp Pharm; 1979 Jan; 36(1):66-8. PubMed ID: 758787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Guidelines for determination of the optimum dosage of E-0686. A new sustained-release preparation of theophylline].
    Miyamoto T; Takishima T; Satake T; Kabe J; Baba M; Mikawa H; Teramichi Y; Iikura Y
    Arerugi; 1986 Apr; 35(4):250-61. PubMed ID: 3741151
    [No Abstract]   [Full Text] [Related]  

  • 29. [S-theophylline levels in patients on theophylline maintenance therapy].
    Pedersen C; Raben H; Lindvig K
    Ugeskr Laeger; 1984 Jan; 146(4):257-9. PubMed ID: 6701988
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theophylline dosing and theophylline level testing in a family practice population.
    Moore LD; Taylor AT
    J Fam Pract; 1988 Jul; 27(1):57-61. PubMed ID: 3392510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rapidly dissolving theophylline tablet.
    Cohen A; Johnson C; Re O
    Curr Ther Res Clin Exp; 1975 May; 17(5):497-505. PubMed ID: 805034
    [No Abstract]   [Full Text] [Related]  

  • 33. Simple method for intravenous-to-oral theophylline dose conversion.
    Wightkin WT; Buchhammer CR
    Clin Pharm; 1982; 1(4):300-1. PubMed ID: 7185527
    [No Abstract]   [Full Text] [Related]  

  • 34. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous theophylline?
    Szymaniak G; Anderer TJ
    Hosp Pharm; 1983 Dec; 18(12):665-6, 670. PubMed ID: 10264360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Individualization of the dosage of oral theophylline with regular increase method and serum level control in 55 asthmatic children (author's transl)].
    Cabanas R; Peña J; Tojo R; Fuster M; Vázquez MC; Cortizo E; Castro-Gago M
    An Esp Pediatr; 1981 Feb; 14(2):89-96. PubMed ID: 7258855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of oral theophylline in asthmatic children: evaluation of a new preparation, "Theolair".
    Haddad ZH; Verma S; Soderberg-Warner M; Kalra V
    Ann Allergy; 1978 Mar; 40(3):167-70. PubMed ID: 637375
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of the Chiou method for determining theophylline dosages.
    Johnson MH; Burkle WS
    Clin Pharm; 1984; 3(2):174-8. PubMed ID: 6723223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concern about theophylline.
    Brady RE
    Pediatrics; 1976 Oct; 58(4):630-1. PubMed ID: 972809
    [No Abstract]   [Full Text] [Related]  

  • 40. Reassessing the therapeutic range for theophylline on laboratory report forms: the importance of 5-15 micrograms/ml.
    Self TH; Heilker GM; Alloway RR; Kelso TM; Abou-Shala N
    Pharmacotherapy; 1993; 13(6):590-4. PubMed ID: 8302682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.